Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Evaluation of rhGH Replacement Therapy in Patients With Pseudohypoparathyroidism Type Ia (PHP Ia)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2007 by University of Milan.
Recruitment status was  Active, not recruiting
Eli Lilly and Company
Information provided by:
University of Milan Identifier:
First received: July 5, 2007
Last updated: NA
Last verified: June 2007
History: No changes posted
No Study Results Posted on for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given
Publications automatically indexed to this study by Identifier (NCT Number):